PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, School of Pharmacy, Seattle, WA 98195, USA; Targeted and Long-Acting Drug Combination Anti-Retroviral Therapeutic (TLC-ART) Program, University of Washington, Seattle, WA 98195, USA; NanoMath, Seattle, WA 98115, USA. Electronic address: perazs@uw.edu.\', \'Department of Pharmaceutics, School of Pharmacy, Seattle, WA 98195, USA; Targeted and Long-Acting Drug Combination Anti-Retroviral Therapeutic (TLC-ART) Program, University of Washington, Seattle, WA 98195, USA.\', \'Department of Pharmaceutics, School of Pharmacy, Seattle, WA 98195, USA; First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.\', \'Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA 98195, USA.\', \'Department of Pharmaceutics, School of Pharmacy, Seattle, WA 98195, USA; Targeted and Long-Acting Drug Combination Anti-Retroviral Therapeutic (TLC-ART) Program, University of Washington, Seattle, WA 98195, USA; Department of Bioengineering, University of Washington, Seattle, WA 98195, USA. Electronic address: rodneyho@uw.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0022-3549(20)30748-610.1016/j.xphs.2020.11.019
?:doi
?:hasPublicationType
?:journal
  • Journal of pharmaceutical sciences
is ?:pmid of
?:pmid
?:pmid
  • 33248057
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 149
is ?:relation_isRelatedTo_publication of
?:title
  • Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all